Cancer stem cells are molecularly characterized based on the expression of various cell surface receptors including integrin a6 (CD49f), integrin b1 (CD29), hyaluronan receptor (CD44), and the stem cell self-renewal transcription factors NANOG, OCT4, and SOX2 (Zheng et al., 2013). This evidence concerns the gene CD44 and cancer.